Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Coloplast A/S Sponsored ADR (CLPBY) had Revenue of $3.93B for the most recently reported fiscal year, ending 2024-09-30.

Quarterly Annual

Figures for fiscal year ending 2024-09-30

Income Statement Financials
Revenue	$3.93B
Net Income	$734.56M
Cost of Goods Sold	$1.27B
Gross Profit	$2.66B
Operating Expenses	$2.87B
Operating Income	$1.06B
Non-Operating Income/Expense	$-134.50M
Pre-Tax Income	$929.83M
Normalized Pre-Tax Income	$929.83M
Income after Taxes	$734.56M
Income from Continuous Operations	$734.56M
Consolidated Net Income/Loss	$734.56M
Normalized Income after Taxes	$734.56M
EBIT	$1.06B
EBITDA	$1.25B
Weighted-Average Shares Outstanding (Basic)	2.25B
Weighted-Average Shares Outstanding (Diluted)	2.25B
Earnings per Share (EPS) (Basic)	$0.33
Earnings per Share (EPS) (Diluted)	$0.33
Balance Sheet Financials
Current Assets	$1.52B
Property, Plant, and Equipment	$821.36M
Long-Term Assets	$5.47B
Total Assets	$6.99B
Current Liabilities	$1.48B
Long-Term Debt	$2.41B
Long-Term Liabilities	$2.90B
Total Liabilities	$4.38B
Common Equity	$2.61B
Tangible Shareholders Equity	$-1.80B
Shareholders Equity	$2.61B
Common Shares Outstanding	2.28B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$402.18M
Cash Flow from Investing Activities	$-194.25M
Cash Flow from Financial Activities	$-220.72M
Beginning Cash	$132.46M
End Cash	$114.58M
Increase/Decrease in Cash	$-17.88M
Stock-Based Compensation	--
Common Stock Dividends Paid	$-686.29M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.02
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.48
Debt to Equity Ratio	0.92
Gross Margin	67.59%
Operating Margin	27.08%
EBIT Margin	27.08%
EBITDA Margin	31.85%
Pre-Tax Profit Margin	23.66%
Profit Margin	18.69%
Free Cash Flow	$234.82M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.56
Inventory Turnover	2.39
Receiveable Turnover	4.87
Days Sales in Receivables	74.94
Return on Equity	28.16%
Return on Tangible Equity	-40.77%
Return on Assets	10.51%
Return on Investments	14.64%
Book Value Per Share	$1.14
Free Cash Flow per Share	$0.10
Operating Cash Flow per Share	$0.18

Data from Zacks Investment Research, Inc.